HMGA2 promotes nasopharyngeal carcinoma progression and is associated with tumor resistance and poor prognosis

被引:2
作者
Ouyang, Xinting [1 ]
Li, Kangxin [1 ]
Wang, Jiaqi [1 ]
Zhu, Weijian [1 ]
Yi, Qiang [1 ]
Zhong, Jinghua [2 ]
机构
[1] Gannan Med Univ, Ganzhou, Jiangxi, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Oncol, Ganzhou, Jiangxi, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2024年 / 13卷
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; HMGA2; invasion metastasis; tumor resistance; prognosis; EPITHELIAL-MESENCHYMAL TRANSITION; GROUP-A PROTEINS; TRANSCRIPTIONAL ACTIVATION; E-CADHERIN; CANCER; AUTOPHAGY; STEM; GENE; EMT; EXPRESSION;
D O I
10.3389/fonc.2023.1271080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nasopharyngeal carcinoma (NPC), as one of the most prevalent malignancies in the head and neck region, still lacks a complete understanding of its pathogenesis. Presently, radiotherapy, concurrent chemoradiotherapy, and targeted therapy stand as the primary modalities for treating NPC. With advancements in medicine, the cure rates for nasopharyngeal carcinoma have been steadily increasing. Nevertheless, recurrence and metastasis persist as the primary reasons for treatment failure. Consequently, a profound exploration of the molecular mechanisms underlying the occurrence and progression of nasopharyngeal carcinoma, along with the exploration of corresponding therapeutic approaches, becomes particularly imperative in the quest for comprehensive solutions to combat this disease. High mobility group AT-hook 2 (HMGA2) is a pivotal protein capable of altering chromatin structure, regulating gene expression, and influencing transcriptional activity. In the realm of cancer research, HMGA2 exhibits widespread dysregulation, playing a crucial role in nearly all malignant tumors. It is implicated in various tumorigenic processes, including cell cycle regulation, cell proliferation, epithelial-mesenchymal transition, angiogenesis, tumor invasion, metastasis, and drug resistance. Additionally, HMGA2 serves as a molecular marker and an independent prognostic factor in certain malignancies. Recent studies have increasingly unveiled the critical role of HMGA2 in nasopharyngeal carcinoma (NPC), particularly in promoting malignant progression, correlating with tumor resistance, and serving as an independent adverse prognostic factor. This review focuses on elucidating the oncogenic role of HMGA2 in NPC, suggesting its potential association with chemotherapy resistance in NPC, and proposing its candidacy as an independent factor in nasopharyngeal carcinoma prognosis assessment.
引用
收藏
页数:9
相关论文
共 75 条
  • [1] Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp
    Alfarouk, Khalid O.
    Stock, Christian-Martin
    Taylor, Sophie
    Walsh, Megan
    Muddathir, Abdel Khalig
    Verduzco, Daniel
    Bashir, Adil H. H.
    Mohammed, Osama Y.
    Elhassan, Gamal O.
    Harguindey, Salvador
    Reshkin, Stephan J.
    Ibrahim, Muntaser E.
    Rauch, Cyril
    [J]. CANCER CELL INTERNATIONAL, 2015, 15
  • [2] Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)
    Au, K. H.
    Ngan, Roger K. C.
    Ng, Alice W. Y.
    Poon, Darren M. C.
    Ng, W. T.
    Yuen, K. T.
    Lee, Victor H. F.
    Tung, Stewart Y.
    Chan, Anthony T. C.
    Sze, Henry C. K.
    Cheng, Ashley C. K.
    Lee, Anne W. M.
    Kwong, Dora L. W.
    Tam, Anthony H. P.
    [J]. ORAL ONCOLOGY, 2018, 77 : 16 - 21
  • [3] Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Bossi, P.
    Chan, A. T.
    Licitra, L.
    Trama, A.
    Orlandi, E.
    Hui, E. P.
    Halamkova, J.
    Mattheis, S.
    Baujat, B.
    Hardillo, J.
    Smeele, L.
    van Herpen, C.
    Castro, A.
    Machiels, J-P
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (04) : 452 - 465
  • [4] Dynamic EMT: a multi-tool for tumor progression
    Brabletz, Simone
    Schuhwerk, Harald
    Brabletz, Thomas
    Stemmler, Marc P.
    [J]. EMBO JOURNAL, 2021, 40 (18)
  • [5] Revised nomenclature for high mobility group (HMG) chromosomal proteins
    Bustin, M
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (03) : 152 - 153
  • [6] The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment
    Cessna, Hannah
    Baritaki, Stavroula
    Zaravinos, Apostolos
    Bonavida, Benjamin
    [J]. CANCERS, 2022, 14 (19)
  • [7] Epithelial to mesenchymal transition (EMT) biomarkers - E-cadherin, beta-catenin, APC and Vimentin - in oral squamous cell carcinogenesis and transformation
    Chaw, S. Y.
    Majeed, A. Abdul
    Dalley, A. J.
    Chan, A.
    Stein, S.
    Farah, C. S.
    [J]. ORAL ONCOLOGY, 2012, 48 (10) : 997 - 1006
  • [8] Nasopharyngeal carcinoma
    Chen, Yu-Pei
    Chan, Anthony T. C.
    Quynh-Thu Le
    Blanchard, Pierre
    Sun, Ying
    Ma, Jun
    [J]. LANCET, 2019, 394 (10192) : 64 - 80
  • [9] Nasopharyngeal carcinoma
    Chua, Melvin L. K.
    Wee, Joseph T. S.
    Hui, Edwin P.
    Chan, Anthony T. C.
    [J]. LANCET, 2016, 387 (10022) : 1012 - 1024
  • [10] A role for ABCG2 beyond drug transport: Regulation of autophagy
    Ding, Rui
    Jin, Shengkan
    Pabon, Kirk
    Scotto, Kathleen W.
    [J]. AUTOPHAGY, 2016, 12 (05) : 737 - 751